228 related articles for article (PubMed ID: 10789229)
21. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival.
Granetzny A; Boseila A; Wagner W; Krukemeyer G; Vogt U; Hecker E; Koch OM; Klinke F
Eur J Cardiothorac Surg; 2006 Aug; 30(2):212-6. PubMed ID: 16829087
[TBL] [Abstract][Full Text] [Related]
22. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
24. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease.
Ohta Y; Shimizu Y; Minato H; Matsumoto I; Oda M; Watanabe G
Ann Thorac Surg; 2006 Feb; 81(2):427-33. PubMed ID: 16427826
[TBL] [Abstract][Full Text] [Related]
25. Is surgery indicated in patients with stage IIIa lung cancer and mediastinal nodal involvement?
Bakir M; Fraser S; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):303-10. PubMed ID: 21685220
[TBL] [Abstract][Full Text] [Related]
26. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
27. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
28. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
29. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
30. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
32. Tumor size and extension of lymph node metastases in N2 lung cancer.
Watanabe Y; Murakami S; Oda M; Ohta Y; Watanabe S; Nozawa H; Kamesui T; Nozaki Y; Nonomura A; Minato H; Kitagawa M
Ann Ital Chir; 1999; 70(6):889-92. PubMed ID: 10804667
[TBL] [Abstract][Full Text] [Related]
33. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
34. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
[No Abstract] [Full Text] [Related]
35. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
Casali C; Stefani A; Natali P; Rossi G; Morandi U
Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
[TBL] [Abstract][Full Text] [Related]
37. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
[TBL] [Abstract][Full Text] [Related]
38. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
39. [Use of endotracheobronchial surgery in conjunction with radiochemotherapy for advanced non-small lung cancer].
Arsen'ev AI; Kanaev SV; Barchuk AS; Vedenin IaO; Klitenko VN; Gel'fond ML; Shulenov AV; Morozova IuA; Barchuk AA; Tarkov SA
Vopr Onkol; 2007; 53(4):461-7. PubMed ID: 17969412
[TBL] [Abstract][Full Text] [Related]
40. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
